Dr Mohammad Amjad Kamal is a Distinguish Adjunct Professor at King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia, where he was a full Professor from March 2011 to March 2013. Prof. Kamal’s overall biochemical research output has culminated in more than 650 publications in internationally respected journals and 65 abstracts at international conferences. His research was pivotal in supporting the development of the novel anti-Alzheimer agents from the laboratory to the clinic via collaboration with Dr Nigel H. Greig (Chief of the Laboratory of Neurosciences in the USA). This research aims to advance the scientific research at KFMRC in providing health translational services to humanity, particularly the local Arab community. He served KFMRC Publication Committee (KPC) as a Coordinator and was selected as a scientific member of Chair "Yousef Abdul Latif Jameel Therapeutic Applications in the Prophet's Medicine". Moreover, he is serving as a regional/editorial member/guest editor of several reputed journals on an honourably basis.